SecBot SecBot
SC 13G/A ·Filed Nov 5, 2026

PRAX

Praxis Precision Medicines, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 12h ago SEC0000315066-26-002828
Passive stake amendment
Actionable Insight • Neutral

FMR's passive 9.2% stake is a routine update with no change in investment stance. Monitor for any future conversion to Schedule 13D, which would signal activist intent, but no such indication exists in this filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$262.59
T+0 close · Nov 5, 2026 · via day close
Latest settled
+23.68%
T+5 · $324.76
Vs SPY
+20.39%
α at T+5
Next horizon
T+20
in 17d
  1. T+0 · Nov 5 $262.59entry
  2. T+1 · 11d ago +5.72%α +5.41% · $277.62
  3. T+5 · 5d ago +23.68%α +20.39% · $324.76
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FMR LLC (Fidelity) filed an amended Schedule 13G disclosing beneficial ownership of 2,565,828 shares of Praxis Precision Medicines common stock as of September 30, 2026, representing 9.2% of outstanding shares. This is a routine passive stake update with no change in investment intent.

Key Financial Metrics

Stake
9.2%
Investor
FMR LLC
Investor Type
mutual fund

Key Facts

  • FMR LLC reported beneficial ownership of 2,565,828 shares of Praxis Precision Medicines common stock as of September 30, 2026
  • The stake represents 9.2% of outstanding shares
  • Filing is an amendment to Schedule 13G, indicating passive investment intent
  • FMR LLC subsidiaries FIAM LLC, Fidelity Management & Research Company LLC, and Strategic Advisers LLC are among the reporting entities
  • Abigail P. Johnson is also reported as a beneficial owner of the same 2,565,828 shares (9.2%)

Financial Impact

2,565,828 shares valued at approximately $200M based on $7.8B market cap and 9.2% stake

ownership percentage

Risk Factors

  • No material risks identified from this routine passive stake filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
89% bullish (27 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0000315066-26-002828
Document: 0000315066-26-002828-index-headers.html0000315066-26-002828
Document: 0000315066-26-002828-index.html0000315066-26-002828
Document: 0000315066-26-002828.txt0000315066-26-002828

Track record

16 reports on PRAX

Performance horizon

5 of 7 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jun 29, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $317.69 Now $310.27 +2.34% settles Feb 12
  2. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $328.13 Now $310.27 −5.44% settles Feb 11
  3. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $332.97 Now $310.27 −6.82% settles Feb 5
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Viewing Entry $262.59 Now $310.27 +18.16% settles Feb 3
  5. Nov 4, 202612d ago Press Release Neutral 1/10 Entry $262.59 Now $310.27 +18.16% settles Feb 3
  6. Oct 29, 202618d ago Institutional Cluster Neutral 2/10 Entry $288.62 Now $310.27 +7.50% settles Jan 27
  7. Jun 29, 202620w ago 8-K Bearish 6/10 Entry $334.79 to $282.12 Now $310.27 +7.32% ▲ +15.73% +18.55% vs SPY
  8. Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $247.98 to $351.81 Now $310.27 +25.12% ▲ +41.87% +37.47% vs SPY
  9. Jun 2, 202623w ago Press Release Neutral 1/10 Entry $278.93 to $367.85 Now $310.27 +11.24% ▲ +31.88% +29.38% vs SPY
  10. May 7, 202627w ago Press Release Bullish 8/10 Entry $333.28 to $305.51 Now $310.27 −6.90% ▼ −8.33% −12.17% vs SPY
Showing 10 of 16

US Market Status

Market Closed · Opens in 7h 37m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026